Immunomodulators - Part A by Rossen Donev
Immodulators, Volume 151 explores the pivotal role immodulators play in regulating immune responses for health and disease management. The book provides an in-depth overview of various classes of immunomodulatory agents, including biologics, small molecules, natural compounds, and synthetic drugs, examining their mechanisms of action and therapeutic applications. Chapters in this new release include Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational Challenges, Advances in Immunomodulation: From Dietary Influence to Computational Precision, iPSC-derived immunotherapy for Tau and Alzheimer's disease, and much more. Additional sections cover Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's Disease, Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding Diseases, Immunomodulator drugs: mechanisms of action and systemic effects, Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancers, Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnata, Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics Approach, Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic Arthritis, and many additional topics.- Proteomics and Metabolomics in Drug Discovery
-
Inflammation in Neuropsychiatric Disorders
-
DNA Repair
-
Regulation of Downstream Targets
-
Structural and Mechanistic Enzymology
-
Enzymes Mechanisms, Dynamics and Inhibition
-
Protein Interactions as Targets in Drug Discovery
-
Metalloproteins and Motor Proteins
-
Control of Cell Cycle and Cell Proliferation
-
Computational Chemistry Methods in Structural Biology
-
Proteomics and Systems Biology
-
Protein Misfolding
-
Inflammatory Disorders - Part B
-
Intracellular Signalling Proteins
-
Protein and Peptide Nanoparticles for Drug Delivery
-
Protein Interaction Networks
-
Ion Channels as Therapeutic Targets, Part A
-
Advances in Protein Chemistry and Structural Biology
-
Combined Quantum Mechanical and Molecular Mechanical Modelling of Biomolecular Interactions
-
Personalized Medicine
-
Peptide and Protein Vaccines
-
Inflammatory Disorders - Part A
-
Apoptosis in Health and Disease - Part B
-
Apoptosis in Health and Disease - Part A
-
Non-heme Iron Enzymes: Structures and Mechanisms
-
Protein Design and Structure
-
Stress and Inflammation in Disorders
-
Chromatin Remodelling and Immunity
-
Insights into Enzyme Mechanisms and Functions from Experimental and Computational Methods
-
Transport Proteins
-
Ion Channels as Therapeutic Targets, Part B
-
Protein Kinases in Drug Discovery
-
Protein Misfolding Diseases
-
Protein Structure Prediction and Analysis
-
Immunotherapy: Magic Bullet to Change the Future Therapeutics
-
Protein Aggregation - Part B
-
Secretory Proteins
-
Protien Aggregation - Part A
-
Molecular Chaperones in Human Disorders
-
Senescence, Senotherapeutics and Mitochondria
-
Immunology for Engineers
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
| SKU | Unavailable |
| ISBN 13 | 9780443345210 |
| ISBN 10 | 044334521X |
| Title | Immunomodulators - Part A |
| Author | Rossen Donev |
| Series | Advances In Protein Chemistry And Structural Biology |
| Condition | Unavailable |
| Binding Type | Hardback |
| Publisher | Elsevier Science Publishing Co Inc |
| Year published | 2026-05-01 |
| Number of pages | 488 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |